Showing results (301-310 of 2,113) with videos related to
Sort By:
Pageof 212
Sub-Cellular Biochemistry|April 30, 2026
Carbonic Anhydrase Inhibitors in OncologyClaudiu T Supuran, Andrea AngeliExpert Opinion on Therapeutic Targets|May 8, 2026
Molecular understanding for therapeutic targeting of hypoxia in breast cancerAndrea Angeli, Claudiu T SupuranBioorganic & Medicinal Chemistry|December 17, 2013
Inhibition of carbonic anhydrases from the extremophilic bacteria Sulfurihydrogenibium yellostonense (SspCA) and S. azorense (SazCA) with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moietiesAhmed M Alafeefy, Hatem A Abdel-Aziz, Daniela Vullo, et al.International Journal for Parasitology. Drugs and Drug Resistance|January 28, 2017
Investigating the antiplasmodial activity of primary sulfonamide compounds identified in open source malaria dataGillian M Fisher, Silvia Bua, Sonia Del Prete, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|July 2, 2013
Carbonic anhydrase inhibitors. Phenols incorporating 2- or 3-pyridyl-ethenylcarbonyl and tertiary amine moieties strongly inhibit Saccharomyces cerevisiae β-carbonic anhydraseSinan Bilginer, Elif Unluer, Halise Inci Gul, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|July 31, 2015
Expression and characterization of a recombinant psychrophilic γ-carbonic anhydrase (NcoCA) identified in the genome of the Antarctic cyanobacteria belonging to the genus NostocViviana De Luca, Sonia Del Prete, Daniela Vullo, et al.Computational and Structural Biotechnology Journal|August 26, 2022
Biochemical, structural, and computational studies of a γ-carbonic anhydrase from the pathogenic bacterium Burkholderia pseudomalleiAnna Di Fiore, Viviana De Luca, Emma Langella, et al.Bioorganic & Medicinal Chemistry Letters|September 14, 2010
Paraoxon, 4-nitrophenyl phosphate and acetate are substrates of α- but not of β-, γ- and ζ-carbonic anhydrasesAlessio Innocenti, Claudiu T SupuranExpert Opinion on Therapeutic Patents|March 26, 2011
Heterocyclic compounds and their uses: a patent evaluation of WO2010151735A2Andrea Scozzafava, Claudiu T SupuranBioorganic & Medicinal Chemistry|May 4, 2007
Carbonic anhydrases as targets for medicinal chemistryClaudiu T Supuran, Andrea ScozzafavaPageof 212